Anhui Anke Biotechnology (Group) Co., Ltd. (SHE:300009)

SHE:300009 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	261.35	299.18	260.23	324.59	322.56	248.07
Trading Asset Securities	936.71	1,145	1,196	842.91	805.43	646.45
Cash & Short-Term Investments	1,198	1,444	1,456	1,167	1,128	894.52
Cash Growth	-24.01%	-0.82%	24.70%	3.50%	26.10%	26.86%
Accounts Receivable	543.5	492.35	597.44	476.3	543.89	475.6
Other Receivables	39.07	30.54	9	11.25	46.96	96.36
Receivables	582.57	522.9	606.44	487.55	590.85	571.96
Inventory	289.14	297.3	235.22	210.48	181.25	155.12
Other Current Assets	22.02	11.03	28.03	45.02	21.53	19.75
Total Current Assets	2,092	2,275	2,325	1,911	1,922	1,641
Property, Plant & Equipment	1,568	1,584	1,434	1,176	881.34	766.66
Long-Term Investments	690.27	515.54	404.38	347.89	188.09	163.14
Goodwill	66.56	66.56	66.56	57.6	57.6	380.2
Other Intangible Assets	416.54	412.32	450.36	275.64	126.22	119.34
Long-Term Deferred Tax Assets	42.59	41.8	29.53	41.8	51.22	39.65
Long-Term Deferred Charges	210.6	223.28	223.8	413.28	386.18	367.14
Other Long-Term Assets	18.34	17.15	17.1	34.41	56.81	27.39
Total Assets	5,104	5,135	4,951	4,257	3,669	3,505
Accounts Payable	199.89	215.02	211.7	151.01	141.11	69.88
Accrued Expenses	115.08	238.6	328.25	240.6	306.76	200.45
Short-Term Debt	5	5	-	3	-	-
Current Portion of Long-Term Debt	-	-	-	-	-	14.01
Current Portion of Leases	10.87	10.71	8.81	6.08	3.3	-
Current Income Taxes Payable	94.59	58.22	43.91	46.88	93.12	71.02
Current Unearned Revenue	17.63	19.34	24.43	27.96	19.51	13.43
Other Current Liabilities	238.02	120.69	229.98	200.27	62.99	103.75
Total Current Liabilities	681.08	667.59	847.08	675.8	626.79	472.54
Long-Term Leases	34.83	38.25	47.82	24.06	23.74	-
Long-Term Unearned Revenue	119.36	121.53	113.52	114.16	107.18	94.68
Long-Term Deferred Tax Liabilities	8.19	8.05	10.01	41.14	7.81	9.07
Total Liabilities	843.47	835.41	1,018	855.17	765.52	576.29
Common Stock	1,673	1,673	1,677	1,673	1,638	1,365
Additional Paid-In Capital	472.16	508.66	519.82	405.73	186.87	442.64
Retained Earnings	2,100	2,058	1,767	1,337	961.26	1,028
Treasury Stock	-114.57	-114.57	-226.22	-207.41	-	-
Total Common Equity	4,085	4,124	3,737	3,209	2,787	2,836
Minority Interest	175.66	175.63	194.93	193.09	116.97	92.85
Shareholders' Equity	4,261	4,300	3,932	3,402	2,904	2,929
Total Liabilities & Equity	5,104	5,135	4,951	4,257	3,669	3,505
Total Debt	50.7	53.96	56.63	33.14	27.04	14.01
Net Cash (Debt)	1,147	1,390	1,399	1,134	1,101	880.5
Net Cash Growth	-24.64%	-0.66%	23.35%	3.03%	25.04%	30.04%
Net Cash Per Share	0.69	0.83	0.84	0.69	0.69	0.54
Filing Date Shares Outstanding	1,672	1,641	1,661	1,589	1,638	1,638
Total Common Shares Outstanding	1,672	1,641	1,661	1,589	1,638	1,638
Working Capital	1,411	1,608	1,478	1,235	1,295	1,169
Book Value Per Share	2.44	2.51	2.25	2.02	1.70	1.73
Tangible Book Value	3,602	3,645	3,220	2,875	2,603	2,336
Tangible Book Value Per Share	2.15	2.22	1.94	1.81	1.59	1.43
Buildings	-	582.74	583.06	564.87	469.79	428.33
Machinery	-	722.81	624.66	562.37	528.17	513.09
Construction In Progress	-	799.75	672.51	445.68	228.75	136.79

Updated Oct 24, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.